Karl Weiss
Department of Infectious Diseases and Microbiology
Maisonneuve-Rosemont Hospital
Faculty of Medicine
University of Montreal
Canada
Name/email consistency: high
- Safety analysis of fidaxomicin in comparison with oral vancomycin for Clostridium difficile infections. Weiss, K., Allgren, R.L., Sellers, S. Clin. Infect. Dis. (2012)
- Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer. Weiss, K. Int. J. Antimicrob. Agents (2009)
- Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Weiss, K., Boisvert, A., Chagnon, M., Duchesne, C., Habash, S., Lepage, Y., Letourneau, J., Raty, J., Savoie, M. Infect. Control. Hosp. Epidemiol (2009)
- Clostridium difficile and fluoroquinolones: is there a link?. Weiss, K. Int. J. Antimicrob. Agents (2009)
- Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004. Weiss, K., Bergeron, L., Bernatchez, H., Goyette, M., Savoie, M., Thirion, D. Int. J. Antimicrob. Agents (2007)
- The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia. Weiss, K., Tillotson, G.S. Chest (2005)
- Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults. Weiss, K., Low, D.E., Cortes, L., Beaupre, A., Gauthier, R., Gregoire, P., Legare, M., Nepveu, F., Thibert, D., Tremblay, C., Tremblay, J. Can. Respir. J. (2004)
- An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis. Weiss, K., Vanjaka, A. Clin. Ther (2002)
- Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada. Weiss, K., De Azavedo, J., Restieri, C., Galarneau, L.A., Gourdeau, M., Harvey, P., Paradis, J.F., Salim, K., Low, D.E. J. Antimicrob. Chemother. (2001)
- A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae. Weiss, K., Restieri, C., Gauthier, R., Laverdière, M., McGeer, A., Davidson, R.J., Kilburn, L., Bast, D.J., de Azavedo, J., Low, D.E. Clin. Infect. Dis. (2001)
- In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae. Weiss, K., de Azavedo, J., Restieri, C., Quach, C., Laverdiere, M., Rubin, E., Gourdeau, M., Low, D.E. J. Antimicrob. Chemother. (2001)
- Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia. Weiss, K., Restieri, C., De Carolis, E., Laverdière, M., Guay, H. J. Antimicrob. Chemother. (2000)
